Changes in immune cell populations in the periphery and liver of GBV-B-infected and convalescent tamarins (Saguinus labiatus)  by Hood, Simon P. et al.
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a  b  s  t  r  a  c  t
Flaviviruses  related  to hepatitis  C virus  (HCV)  in  suitable  animal  models  may  provide  further  insight into
the role  that  cellular  immunity  contributes  to spontaneous  clearance  of  HCV.  We  characterised  changes
in lymphocyte  populations  in  tamarins  with  an  acute  GBV-B  infection,  a hepatitis  virus  of  the  ﬂaviviri-
dae.  Major  immune  cell  populations  were  monitored  in  peripheral  and  intra-hepatic  lymphocytes  at  high
viraemia  or  following  a  period  when  peripheral  virus  was  no  longer  detected.  Limited  changes  in  major
lymphocyte  populations  were  apparent  during  high  viraemia;  however,  the  proportions  of  CD3+ lym-
phocytes  decreased  and  CD20+ lymphocytes  increased  once  peripheral  viraemia  became  undetectable.
Intrahepatic  lymphocyte  populations  increased  at both  time  points  post-infection.  Distinct  expression
patterns  of  PD-1,  a marker  of  T-cell activation,  were  observed  on peripheral  and  hepatic  lymphocytes;
+notably  there  was  elevated  PD-1  expression  on  hepatic  CD4 T-cells  during  high  viraemia,  suggesting
an  activated  phenotype,  which  decreased  following  clearance  of peripheral  viraemia.  At times when
peripheral  vRNA  was  not  detected,  suggesting  viral  clearance,  we were  able  to readily  detect  GBV-B  RNA
in the  liver,  indicative  of  long-term  virus  replication.  This  study  is  the  ﬁrst  description  of  changes  in
lymphocyte  populations  during  GBV-B  infection  of  tamarins  and  provides  a foundation  for  more  detailed
investigations  of the  responses
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1. Introduction
Hepatitis C virus (HCV) establishes a chronic infection in
approximately 70% of infected individuals (Bowen and Walker,
2005; Chisari, 2005). The mechanisms by which the remainder
eliminate detectable infection are not fully understood, though a
vigorous multispeciﬁc CD4+ and CD8+ T-cell response is thought
to contribute to viral clearance (Chang et al., 2001; Lechner et al.,
2000; Thimme  et al., 2001, 2002). Understanding the mechanisms
underlying natural clearance is important both in designing
immunotherapies and prophylactic vaccines. An inability to clear
virus may, in part, be due to a failure of CD4+ T-cells to support
Open access under CC BY-NC-ND license.a sufﬁciently robust virus-speciﬁc CD8+ T-cell response, implying
that both T-cell subsets should be targeted in any therapeutic strat-
egy (Chang et al., 2001). One obstacle to establishing the precise
2 Present address: Faculty of Health and Wellbeing, Shefﬁeld Hallam University,
Howard Street, Shefﬁeld S1 1WB, UK.
3 Present address: St George’s, University of London Medical School at University
of  Nicosia, 93, Agiou Nikolaou Street, Engomi, PO Box 24005, Nicosia 2408, Cyprus.
-ND license.
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echanism(s) of clearance is that many infections may  be asymp-
omatic, hence the identiﬁcation, monitoring and acquisition of
amples from acutely HCV-infected patients is difﬁcult.
Chimpanzees are susceptible to HCV however numerous
onstraints preclude their use. The infection of tamarins and mar-
osets with GBV-B represents an attractive surrogate model for the
tudy of HCV infection in man  (Beames et al., 2000, 2001; Lanford
t al., 2003; Jacob et al., 2004). GBV-B is a ﬂavivirus closely related
o HCV and causes an acute self-limiting hepatitis: high viraemia is
ypically followed by viral clearance from the periphery within 18
eeks of infection (Beames et al., 2000, 2001; Bright et al., 2004).
his model is applicable to the investigation of acute HCV pathogen-
sis, antiviral drug development and pre-clinical evaluation of can-
idate prophylactic vaccines (Butkiewicz et al., 2000; Beames et al.,
001; Bright et al., 2004; Jacob et al., 2004; Rijnbrand et al., 2005).
ince GBV-B is most likely to have arisen in tamarins (Stapleton
t al., 2011) we studied GBV-B-induced acute hepatitis in red-
ellied tamarins to better understand changes in lymphocyte popu-
ations in both the periphery and liver, associated with the sponta-
eous resolution of the ﬂavivirus infection. We  explored changes in
ey cell populations, CD4+, CD8+ and CD20+ cells, in the blood and
he liver, between animals with high peripheral viraemia and those
n a convalescence phase in which virus was undetectable in the
eriphery. Furthermore, since the mechanism of T-cell exhaustion
as been implicated in persistence of several viruses, including HCV
Hofmeyer et al., 2011), we characterised the presence of the cell
urface protein Programmed Death-1 (PD-1) on T-cells. Dysfunc-
ional HCV-speciﬁc CD8 T-cells displaying up-regulated PD-1 and
D-1 ligand expression have been identiﬁed in the blood and liver of
hronically infected individuals (Yao et al., 2007) and the reversal of
-cell exhaustion, evidenced by reduced PD-1 expression, has been
ssociated with spontaneous clearance of chronic HCV infection
Raghuraman et al., 2012). In HCV-infected chimpanzees differ-
nces have been reported with higher intrahepatic PD-1 mRNA
evels reported in chronically infected individuals by Rollier et al.
2007), while others have reported that PD-1 mRNA levels are not
redictive of acute/chronic outcome of infection (Shin et al., 2013).
e showed that in the convalescent phase of GBV-B infection a
ecrease in CD3+ and a corresponding increase in CD20+ lympho-
ytes occurred. Intrahepatic T- and B-lymphocyte populations were
reater at high viraemia and convalescence than pre-infection.
A prerequisite to optimal exploitation of this model is a clear def-
nition of the pathogenesis and naturally occurring host immune
esponse against GBV-B in tamarins. We  identiﬁed signiﬁcant
mmune inﬁltration into the liver at high viraemia as well as in two
f the four animals in the convalescent phase, concomitant with
ares in serum ALT levels and vRNA was isolated from the livers of
ll animals, including those with undetectable peripheral viraemia.
ntibodies against Core have only been reported for two tamarins
Nam et al., 2004; Bukh et al., 2008); our data on the limited immune
esponses to GBV-B NS3 are broadly consistent with the production
f such antibodies in tamarins and marmosets (Beames et al., 2000;
anford et al., 2003; Martin et al., 2003; Woollard et al., 2008).
This is the ﬁrst description of the changes in a marker of T-
ell activation/exhaustion on key immune cell populations in acute
BV-B infection of tamarins and the ﬁrst report of an infection in the
iver persisting when virus in no longer detected in the blood. These
ata provide a foundation for further immunological and patholog-
cal studies to dissect fully the mechanisms underlying natural viral
learance in this valuable surrogate model of acute HCV infection.
. Materials and methods.1. Animals and virus inoculum
Eight purpose-bred red-bellied tamarins (Saguinus labiatus)
ere used. Animals were housed and maintained in accordancech 179 (2014) 93– 101
with the United Kingdom Animals (Scientiﬁc Procedures) Act 1986
and Home Ofﬁce guidelines for care and maintenance of non-
human primates. All animals were inoculated intravenously with
1 × 107 genome equivalents (ge) of GBV-B in serum. One group
of four animals (animals W1,  W2,  W4,  W11) was terminated at
6 weeks post-infection (wpi) and one group (animals W3,  W5,  V7,
V8) was terminated following clearance of detectable virus from
the periphery (approximately 24 wpi).
2.2. Quantiﬁcation of GBV-B vRNA
To quantify GBV-B vRNA from the periphery, total RNA was
extracted from 140 l serum using the QIAamp Viral RNA Mini kit
(Qiagen, UK). Core sequences were quantiﬁed in duplicate using
the RNA Ultrasense One-step quantitative RT-PCR system. Primers
558F and 626R (Beames et al., 2000) were used at a concentration
of 400 nM and 900 nM,  respectively. The probe (5′ FAM-AGC GCG
ATG CTC GGC CTC GTA AT-BHQ1 3′) was  used at a concentration
of 200 nM.  Reverse transcription was performed at 50 ◦C for 15 min
followed by ampliﬁcation for 40 cycles (95 ◦C, 60 s; 62 ◦C, 30 s; 72 ◦C,
30 s). Standards to determine ge were derived from synthetic GBV-
B RNA in vitro transcribed (IVT) from a plasmid (MEGAscript SP6;
Ambion, USA). Serially diluted IVT RNA was quantiﬁed using a Pois-
son distribution; the limit of quantiﬁcation was  102 ge/ml serum.
To quantify GBV-B vRNA from liver tissue, total RNA was
extracted from a 0.5 cm3 frozen section of liver in 1 ml  RLT buffer
(Qiagen RNeasy Mini Kit; Qiagen, UK). The tissue was  homogenised
using a 50 M sterile Medicon unit (BD Biosciences) attached to
a Medimachine (Dako), following the manufacturers’ instructions.
RNA was puriﬁed from the homogenate using the RNeasy Mini
Kit (Qiagen) following the manufacturer’s instructions. RNA was
quantiﬁed and the concentration adjusted to 0.2 g/l.  vRNA was
quantiﬁed as described for serum vRNA levels and titres expressed
per 400 ng total RNA (equating to approximately 10,000–15,000
cells). The limit of quantiﬁcation was  7.6 × 10−2/400 ng total RNA.
2.3. Quantiﬁcation of serum liver enzymes
To indirectly assess liver damage, serum levels of alanine amino-
transferase (ALT) and glutamate dehydrogenase (GLDH) were
measured using a Kodak Ektachem automated analyser (Kodak
Ltd. UK Suppliers, Orthochemical Diagnostics, Amersham, UK). Pre-
infection samples were also assessed for each animal.
2.4. Isolation of intrahepatic lymphocytes (IHL)
Isolation of IHL from the liver retrieved at termination was per-
formed on fresh tissue using adapted methods (Heydtmann et al.,
2006; Nakamoto et al., 2008). The liver was  washed at 37 ◦C by per-
fusion with 1 × HBSS (Life Technologies, UK) supplemented with
0.5 mM EGTA, 10 mM HEPES and 50 g/ml gentamycin. Hepato-
cytes were disaggregated by perfusion with collagenase solution
(1 mg/ml  collagenase type II [Life Technologies] in 1× HBSS). The
capsule was removed and the liver ﬁnely diced and incubated in
collagenase solution containing 1 g/ml DNaseI  (Sigma–Aldrich) at
37 ◦C for 1 h. IHL were gravity ﬁltered through a 100 m nylon mesh
and puriﬁed over a Ficoll-Paque Plus (GE Healthcare, UK)  density
gradient. IHL were cryopreserved in 80% foetal calf serum (FCS) and
10% dimethylsulfoxide (DMSO) in 1× RPMI. IHL were available from
one uninfected tamarin from a parallel study.
2.5. Analysis of T-cell and B-cell populations by ﬂow cytometryPBMC and IHL (available at termination only) were washed in
1× RPMI containing 1% FCS, pelleted and resuspended in CellWash
(BD Biosciences, Oxford, UK) containing 1% FCS. Cells (3.5 × 105 cells
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er well in a 96-well round-bottom plate) were stained with Aqua
IVE/DEAD Fixable stain (Life Technologies). For immunopheno-
yping, cells were stained with pre-titrated amounts of CD3-FITC
clone SP34, BD), CD4-PE-Cy7 (clone L200, BD), CD8-APC (clone LT8,
bD Serotec, Kidlington, UK) and CD20-PE (clone H299 (B1), Beck-
an  Coulter, High Wycombe, UK). For analysis of PD-1, cells were
tained with PD-1-PE (clone eBioJ105, eBioscience, Hatﬁeld, UK) or
E-labelled isotype-matched control antibody with CD3, CD4 and
D8 as above. Following staining at room temperature for 30 min
ith agitation at 180 rpm, cells were washed twice, resuspended
n 2% (v/v) formaldehyde in PBS and stored at 4 ◦C until analysis.
ata acquisition was performed on a BD FACS CantoII system and
nalysed using BD FACS DIVA v6.1.2. Spectral compensation was
pplied using either BD CompBeads or single-stained cells.
.6. Statistical analysis
Peripheral lymphocyte populations pre- and post-infection
ere compared using a two-tailed paired t-test. Differences in the
bsolute percentage of PD-1+ lymphocytes were assessed by a two-
ailed unpaired t-test. Differences in PD-1 expression levels (MFI)
ere assessed using a Mann–Whitney U-test. Analysis was per-
ormed using Prism v5.03 (GraphPad Software, CA, USA).
.7. Analysis of IFN- production by IHL
To assess IFN- production in response to NS3 peptide stim-
lation, peptides (20mer with 10 residue overlap) spanning the
BV-B NS3 region (residue 941–1560; 61 peptides; Sigma–Aldrich)
ere used. Sufﬁcient cells were available for analysis of six of
he eight animals. Thawed IHL were resuspended in 10 ml  R10
edium (1× RPMI containing 50 U/ml penicillin, 50 g/ml strep-
omycin, 10% foetal calf serum; Life Technologies) and incubated
or 4–6 h at 37 ◦C. Cells were pelleted and resuspended in RPMI;
 × 106 cells/ml; 5 × 105 cells were aliquoted per well in a 96-well
ound bottomed plate. IHL were stimulated for 2 h at 37 ◦C with one
f six peptide pools comprising 10 or 11 peptides, 2 g/ml of anti-
D28 (clone CD28.2, BD) and 1 g/ml of anti-CD49d (clone L25, BD).
 combination of 50 ng/ml phorbol 12-myristate 13-acetate and
 M ionomycin (both Sigma–Aldrich) diluted in DMSO/RPMI was
sed as a positive control and 1% (v/v) DMSO was used as a negative
ontrol. Brefeldin A (Sigma–Aldrich) was added to all wells (ﬁnal
oncentration, 10 g/ml) and the plate was incubated overnight at
7 ◦C. Cells were stained with Aqua LIVE/DEAD Fixable stain and
urface stained with PE-CD3, PE-Cy7-CD4 and APC-CD8 as before.
ells were ﬁxed and permeabilised using Fix and Perm solution A
An der Grub, Vienna, Austria), washed and permeabilised using Fix
nd Perm solution B and incubated with either FITC-IFN-  (clone
-D1K, Mabtech, Sweden) or an isotype-matched control antibody
t room temperature for 30 min  with agitation at 180 rpm. Cells
ere washed twice with CellWash (BD), resuspended in 2% (v/v)
ormaldehyde in PBS and stored at 4 ◦C until analysis. Data were
cquired as before. The gate for IFN- positive cells was set to
xclude 99.9% of cells stained with the isotype-matched control
ntibody.
.8. Histological analysis of liver tissue
Sections (4 m)  were cut from formalin-ﬁxed, parafﬁn-
mbedded liver taken at termination. Sections were mounted onto
lass slides, de-waxed using xylene and the tissue re-hydrated
hrough an ethanol series. Haematoxylin and eosin (H&E) staining
as performed, liver morphology was visualised by microscopy
Nikon Eclipse E400) and images captured using the Metaviewch 179 (2014) 93– 101 95
software (Meta Imaging software, MDS  Analytical Technologies
Ltd., Berkshire, UK).
3. Results
3.1. Characterisation of GBV-B infection in red-bellied tamarins
Peripheral viral dynamics were broadly comparable early post-
infection, with all animals becoming viremic 2 days post-infection
and viral RNA levels reaching a plateau at 108–109 ge/ml serum
4–6 weeks post infection (wpi) (Fig. 1A). Levels of ALT ﬂared
slightly in all animals at the time of infection (full data set not
shown). Four animals were terminated at 6 wpi when viraemia
was in excess of 108 ge/ml in each animal. Intracellular vRNA was
detected at high levels in liver tissue (>1 × 105 ge GBV-B/400 ng
total RNA) in these animals (Fig. 1B) but no second ﬂare in liver
enzymes was detected (data not shown). Peripheral virus in the
remaining four animals proceeded, with comparable viral loads
to 10 wpi; thereafter two tamarins (W3  and V7) rapidly sup-
pressed viral replication to undetectable levels (convalescence) by
14 wpi, one (V8) maintained viraemia until 18 wpi and viraemia
was no longer detectable in the ﬁnal animal (W5) by 21 wpi  fol-
lowing a brief period of viral recrudescence between weeks 17
and 21. None of the four convalescent animals had detectable
peripheral viraemia at the time of sacriﬁce (22 wpi  (W3  and
V7) and 23 wpi  (W5  and V8) (Fig. 1A) but, signiﬁcantly, liver-
associated intracellular vRNA was detected in these animals at
levels between 3 × 102 and 2 × 103 ge GBV-B/400 ng total RNA
(Fig. 1B). In all four animals that were allowed to proceed to con-
valescence, a ﬂare in ALT levels was observed around 5–6 wpi,
concurrent with a minor drop in vRNA levels. Further enzyme
ﬂares were coincident with the initial decline in vRNA levels
in all animals and the clearance of recrudesced virus from W5
(Fig. 1C).
3.2. Phenotyping of peripheral lymphocytes
Prior to infection, during the acute phase viraemia and after
clearance of viraemia CD3+ T-cells constituted the majority of
the peripheral lymphocyte population in all animals (Fig. 2A).
The remainder of the lymphocyte population was predominantly
CD20+ (Fig. 2B). A small proportion (typically <10%) of the lympho-
cyte population was CD3− CD20−. At high viraemia three of the
four tamarins had a small increase in the percentage of peripheral
CD3+ T-cells over pre-infection levels (Fig. 2A). This increase was
associated with a trend towards increased CD4+ T-cells and a sig-
niﬁcant decrease (P = 0.015) in CD8+ T-cells (Fig. 2C and D). Changes
in CD20+ B-cells were less consistent (Fig. 2B).
In all four convalescent animals the percentage of CD3+ T-cells
was lower than (P = 0.004), while the percentage of CD20+ B-cells
was higher than (P < 0.001, Fig. 2A and B) that of the pre-infection
samples. There was a trend towards a lower number of CD4+
T-cells and a signiﬁcantly greater number (P = 0.035) of CD8+ T-cells
(Fig. 2C and D). In all animals and at both time points tested the CD3+
T-cell population was  comprised primarily of CD4+ cells (>67%)
with the remainder of the CD3+ population being predominantly
CD8+ (Fig. 2C and D).
3.3. Phenotyping of intrahepatic lymphocytes
Pre-infection IHL were not available thus data were compared to
IHL from an unrelated naive tamarin, which were predominantly
CD3− CD20− (Fig. 2A and B). By contrast, the IHL from the ani-
mals terminated at high viraemia had a greater percentage of CD3+
and CD20+ cells (Fig. 2A and B). The percentages of CD4+ and CD8+
T-cells in three of the tamarins were similar to those seen in the
96 S.P. Hood et al. / Virus Research 179 (2014) 93– 101
Fig. 1. Dynamics of GBV-B infection in red-bellied tamarins. (A) Viral load was monitored at weekly intervals in eight animals inoculated with 107 genome equivalents of
infectious serum. Red lines represent animals terminated at 6 weeks post-infection. Animals displayed uniform viraemia proﬁles; hence symbols are omitted for clarity; blue
lines  indicate animals terminated in the convalescent phase. Dashed line indicates the limit of quantiﬁcation of the qRT-PCR assay (100 ge/ml serum). (B) Viral load in the
liver  is presented as copies of virus per 400 ng total RNA (approximately 10,000–15,000 cells) for each animal. The limit of quantiﬁcation was 7.6 × 10−2/400 ng total RNA.
Red  bars indicate the animals terminated at 6 wpi; blue bars indicate the animals terminated in convalescence. (C) Changes in serum liver enzyme levels during infection are
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aive animal. The fourth animal (W2) had a higher percentage of
D4+ T-cells and a lower percentage of CD8+ T-cells (Fig. 2C and
). IHL isolated from the four convalescent tamarins exhibited two
ifferent patterns. The percentages of CD3+ and CD20+ cells in the
HL from tamarins W3 and V8 were similar to those seen in IHL
rom animals terminated at high viraemia while the percentage of
D3+ and CD20+ cells in tamarins W5 and V7 were comparable to
hose of the naive animal (Fig. 2A and B). In all four convalescent
amarins a signiﬁcant proportion (≥40%) of the IHL fraction was
D3− CD20− (Fig. 2A). The percentage of CD4+ and CD8+ T-cells
n three of the convalescent tamarins was similar to that seen in
he naive animal. In contrast the fourth tamarin (W5) had a greater
ercentage of CD8+ T-cells and a lower percentage of CD4+ T-cells
Fig. 2C and D).re indicated for pre- and post-infection time points alongside peripheral viral load
3.4. PD-1 expression on peripheral and intrahepatic CD3+ T
lymphocytes
Distinct patterns of PD-1 expression were observed on periph-
eral and intrahepatic lymphocytes. Peripheral PD-1 expression was
typically uniform with a high frequency of cells (mean 76% of CD3+
cells) staining with low intensity (mean MFI  1188), while PD-1
expression on IHL was more heterogeneous. Representative his-
tograms and gating strategy are shown in Supplementary Fig. S1. A
high percentage of both T-cell subsets in the periphery expressed
PD-1 prior to infection (Fig. 3A). At high viraemia two  tamarins
(W1  and W2)  retained a high percentage of PD-1-expressing CD4+
and CD8+ T-cells with levels comparable to those prior to infec-
tion. By contrast, of the remaining two tamarins one had a 2-fold
S.P. Hood et al. / Virus Research 179 (2014) 93– 101 97
Fig. 2. Peripheral and hepatic lymphocyte dynamics during GBV-B infection of red-bellied tamarins. Percentage of lymphocyte fraction (as determined by forward scatter
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bnd  side scatter characteristics) positive for (A) CD3 and (B) CD20. Percentage of CD
f  infection at which they were sacriﬁced. Lymphocytes from a naive animal, G20, a
ecrease and one had a 10-fold decrease in the percentage of PD-1-
xpressing CD4+ and CD8+ T-cells. In the four tamarins that cleared
nfection there was a signiﬁcant decrease in the percentage of PD-1-
xpressing CD4+ T-cells and CD8+ T-cells compared to pre-infection
evels (P < 0.001). As several reports have indicated that the level of
D-1 expression may  be a more informative indicator than abso-
ute percentage of positive cells (Rutebemberwa et al., 2008; Shen
t al., 2010; Vali et al., 2010), we determined the MFI  for each
opulation of T-cells. Trends for PD-1 expression level were com-
arable to those observed for percentages of positive cells, i.e. a
igniﬁcant reduction in PD-1 levels on CD4+ (P = 0.029) and CD8+
P = 0.004) cells in convalescent tamarins relative to pre-infection
evels (Fig. 3B).
Supplementary material related to this article can be found,
n the online version, at http://dx.doi.org/10.1016/j.virusres.
013.11.006.
A distinct pattern of PD-1 expression was observed on IHL. Rela-
ive to IHL from a naive animal, CD4+ T-cells from viremic tamarins
isplayed elevated PD-1 levels, both in percentage terms and rel-
tive expression level (Fig. 3C and D). In convalescent animals,
D-1 levels were signiﬁcantly lower than during the viremic phase
absolute numbers, P < 0.001; relative expression level, P = 0.029)
nd approached those of the naive animal. PD-1 expression on
D8+ IHL was largely unchanged from naive cells at either time of
nfection. However, only one naive sample was available for com-
arison, thus deﬁnitive baseline levels of PD-1 expression could not
e established.ction positive for (C) CD4 and (D) CD8. Animals are grouped according to the phase
resented by a black diamond.
3.5. Histological analysis of liver tissue
Liver morphology in all tamarins was evaluated against a GBV-
B-naive tamarin (Fig. 4A). Varying degrees of immune inﬁltration
were observed around the portal tracts in all animals termi-
nated at high viraemia (Fig. 4B–E). Marked immune inﬁltration
was observed in two convalescent animals (W5  and V7) partic-
ularly around the portal tracts and within the sinusoids of the
parenchyma, whereas W3  and V8 displayed levels of immune ﬁl-
tration similar to those of the naive animal (Fig. 4F–I).
3.6. Cellular immune responses against GBV-B NS3 in CD3+ IHL
Sufﬁcient IHL were available from six animals for analysis of cel-
lular immunity. Responses against GBV-B NS3 were determined by
intracellular cytokine staining of IFN- following peptide stimula-
tion. A low frequency CD4+ response to a single peptide pool was
detected in one animal (W4) at high viraemia. An additional animal
(V7) raised a CD4+ response to a different peptide pool in the con-
valescent phase. CD8+ T-cell responses were detected only in two
convalescent animals (W5  and V7). Two  responses were at low fre-
quency; a third response was detected at high frequency (∼15% of
CD8+ T-cells; Supplementary material, Fig. S2).
Supplementary material related to this article can be found,
in the online version, at http://dx.doi.org/10.1016/j.virusres.
2013.11.006.
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Fig. 3. Analysis of PD-1 expression on peripheral and intrahepatic CD3+ lymphocytes from GBV-B-infected tamarins. (A and C) Proportion of CD4+ and CD8+ cells positive for
PD-1  expression in PBMC and IHL prior to infection, during the viremic (6 wpi) and convalescent phase (24 wpi). (B and D) Median ﬂuorescence intensity (MFI) of PE-PD-1
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. Discussion
Deﬁning T-cell dynamics associated with the natural clearance
f HCV is essential to understanding the key immune responses
enerated and so inform the development of effective anti-HCV
mmunotherapies and even prophylactic vaccines. The GBV-B
amarin model of acute viral hepatitis, can aid this investigation
y allowing description of the phenotype of immune cell subsets
ost-infection and following natural clearance of a hepatotropic ﬂa-
ivirus, including direct analysis of the liver. Here we have deﬁned T
nd B lymphocyte populations isolated not only from the periphery
ut also the liver at a period of high viraemia or in the subsequent
onvalescence period, when serum viraemia was undetectable.
urprisingly there was direct evidence of on-going virus replication
n the liver. This observation has implications for understanding the
mmune responses involved not only in the initial clearance of acute
epacivirus infections but also the potential for establishment of
hronic infection hitherto underestimated in this model.
Phenotyping of the peripheral lymphocyte population revealed
hat, in three of four animals terminated at 6 wpi with high
iraemia, CD3+ T-cell levels were greater than pre-infection levels
eﬂecting an increase in the proportion of CD4+ T-cells. While speci-
city of T-cells for antigens other than NS3 was not investigated
ue to limiting cell numbers this may  correspond to the strong
ustained multispeciﬁc peripheral CD4+ T-cell response associated
ith the clearance of HCV in humans (Lechner et al., 2000; Chang
t al., 2001; Thimme  et al., 2001). A signiﬁcant decrease in the per-
entage of peripheral CD3+ T-cells compared with pre-infectionells stained with PE-labelled isotype-matched control antibody; error bars indicate
panels). Signiﬁcant differences between groups are indicated by relevant p values.
samples coincided with a signiﬁcant increase in the percentage of
CD20+ B-cells in the four tamarins terminated in the convalescence
period. The increase in CD20+ B-cells is consistent with reports of
anti-NS3 antibody production peaking towards the end of infection
and declining following clearance of viraemia (Beames et al., 2000;
Martin et al., 2003).
Since the liver is the focal point of virus replication, we inves-
tigated changes in intrahepatic lymphocyte populations. In both
high viremic and convalescent phases there was  a greater per-
centage of CD3+ T-cells and CD20+ B-cells compared to the naïve
tamarin. In contrast to marmosets (Jacob et al., 2004), the T-cell
population comprised both CD4+ and CD8+ subsets that remained
proportionally comparable to those in the uninfected animal. The
magnitude of this increase was  limited, however, in two  conva-
lescent animals (W5  and V7) in which the combined CD3+ and
CD20+ population constituted <20% of the lymphocyte fraction.
In both GBV-B-infected and uninfected tamarins a signiﬁcant per-
centage of the IHL were CD3− CD20−. There are reports of higher
proportions of NK cells (which are CD3− CD20−) in the liver than in
the periphery of humans and mice (Crispe, 2003). Deﬁnitive iden-
tiﬁcation of antibodies cross-reactive for tamarin CD16 and CD56
(as markers of NK cells) was  not achieved therefore the phenotype
of this population of cells could not be conﬁrmed.
In a number of viral infections (Barber et al., 2006; Day  et al.,
2006) the failure to clear viraemia is associated with evidence of
T cell exhaustion, while a single case of naturally resolving HCV
infection was  associated with a reversal of the exhausted pheno-
type (Raghuraman et al., 2012). We  investigated PD-1 expression on
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-cells in GBV-B-infected tamarins to compare patterns of expres-
ion to those reported in acute HCV infection. The percentage of
D-1+ CD4+ cells and relative PD-1 expression levels in IHL were
igniﬁcantly higher in viremic animals than in naïve and conva-
escent animals. By contrast, PD-1 expression on CD8+ T-cells was
omparable between the two groups and was generally lower than
n CD4+ T-cells. Notably PD-1 expression patterns on intrahepatic
D4+ T-cells appear typical of those seen on HCV-speciﬁc CD8+
-cells in the periphery in individuals that resolve HCV infection
Urbani et al., 2006; Kasprowicz et al., 2008; Nakamoto et al., 2008)rminated at high viraemia; (F–I) tamarins terminated at convalescence. Lymphoctye
but with higher levels of PD-1 on CD4+ IHL rather than on CD8+
IHL. While we have observed a GBV-B infection persisting in the
periphery of a tamarin for 40 weeks (unpublished data), the limited
number of animals with an infection reaching this stage currently
precludes planned analysis of acute and long-term infections. Shin
and colleagues studied intrahepatic PD-1 mRNA levels from HCV-
infected chimpanzees (Shin et al., 2013) and found that while levels
increased following infection, over the 28-week period of investi-
gation little difference between the patterns of mRNA levels was
noted between the two  animals which controlled their infection
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nd the three that still had detectable viraemia at the end of the
tudy. However, Rollier et al., reported elevated PD-1 mRNA levels
n chronic infection in contrast to lower levels in the two animals
hich cleared infection, as noted in HCV infection (Rollier et al.,
007). Thus, a study whereby we could collate information from
ndividual long-term GBV-B infections in tamarins would add to
he description of the PD-1 levels in this model and in relation to
CV infection of humans.
The relatively low percentage of PD-1+ CD4+ and CD8+ IHL from
he naïve animal contrasts with the higher percentage of peripheral
D-1+ T-cells pre-infection. PD-1 expression levels were markedly
educed in two tamarins with high viraemia, while all convales-
ent animals had signiﬁcantly reduced PD-1 expression on both
D4+ and CD8+ T-cells. The mechanism underlying this reduction
n PD-1+ peripheral T-cells is unclear but may  include recruitment
f PD-1+ cells to sites of viral replication or a more systemic down-
egulation of PD-1 expression. The high percentage of PD-1+ T-cells
rior to infection was surprising given the low percentage of PD-1+
-cells in healthy humans (Vali et al., 2010). While it is possible that
he antibody used is capable of detecting only high levels of PD-1,
here are no identiﬁed alternatives that cross react with the tamarin
omologue and it is expected to have a sufﬁcient dynamic range
o detect low levels of PD-1 as evidenced by the heterogeneous
taining pattern seen on IHL (Supplementary Fig. 1C). A possible
xplanation stems from the fact that tamarins are often born as
izygotic twins and are natural bone marrow chimaeras (Watkins
t al., 1990). A high level of PD-1 expression, as well as limited MHC
olymorphism (Watkins et al., 1990, 1991; Mee  et al., 2011) may
lay a role in the tolerance required. Future studies could employ
n evaluation of PD-1 messenger RNA levels to further support the
ata.
The increase in the proportion of CD3+ T-cells in the IHL of
ll animals suggests a role for a strong intrahepatic cell-mediated
mmune response in GBV-B clearance. Three of six tamarins pro-
uced a detectable response against NS3 though no pattern to
he response was noted. The limiting numbers of IHL led us to
mploy pools of overlapping 20mer peptides, which may  bind sub-
ptimally to MHC  class I molecules. Furthermore the low number
f CD3+ cells recovered in the IHL fraction limited the assay sen-
itivity thus some low-level responses may  have been missed.
imilarly, due to the limited volume of peripheral blood samples
vailable to this study, an investigation of responses in the periph-
ry was not possible. Due to a current limitation in availability
f cross-reactive antibodies, only IFN- responses were investi-
ated, though we recognise that CD4+ T-cells in particular may  be
ore likely to produce TNF- and/or IL-2 in response to peptide
timulation. Hence, while our data are broadly consistent with the
roduction of IFN- by marmoset IHL in response to NS3, NS4A and
S5B peptide stimulation (Woollard et al., 2008), and suggestive
f a T-cell response, the intrahepatic T-cell responses likely extend
eyond those described here. The identiﬁcation of additional cross-
eactive antibodies and immunodominant GBV-B epitopes could
llow us to characterise more fully the immune response to the
irus, building on these preliminary data.
Serum vRNA was undetectable in all four convalescent tamarins
or at least 3 weeks prior to sacriﬁce. Immune inﬁltrate was clearly
vident in two tamarins (W5  and V7), but far lower in the remaining
wo tamarins, implying recovery of normal liver morphology in
hese animals. Comparable staining patterns have been previ-
usly reported in GBV-B-infected animals (Karayiannis et al., 1989;
artin et al., 2003; Jacob et al., 2004) and were observed in the ani-
als terminated at high viraemia. However, liver-associated GBV-B
NA was readily isolated and quantiﬁable by RT-PCR from all four
onvalescent animals, albeit to lower levels than those animals at
he peak of infection. Hence, even at times when virus has appar-
ntly been ‘cleared’ from the blood, there is evidence of on-goingch 179 (2014) 93– 101
virus replication in liver tissue which is further supported by evi-
dence of immune activation in W5 and V7 observed at the same
time point as the anti-NS3 response was detected. Our observa-
tions clearly indicate that apparent clearance of GBV-B from the
periphery does not correlate with elimination of virus from the
liver, a characteristic of other hepaciviruses where an occult infec-
tion underlines the persistent nature of infection. Such a reservoir
of virus may  provide the basis for recrudescence, as was observed
in tamarin W5.  However, it is not possible to deﬁnitively state that
GBV-B has established an occult infection given the relatively short
time span of this experiment: longer-term studies will be required
to determine if liver-associated virus replicates at much later time
points. Further, an investigation of the nature of the virus isolated
to determine if it may  be truly infectious would support the concept
of establishment of an occult infection.
The immune response seen in W5  and V7 may  be an effec-
tive response controlling infection or an example of a chronic
immune response to low levels of virus that could cause secondary
liver-associated pathologies, thus whether the tamarin immune
response eradicates GBV-B or merely maintains viral replication
at a low level warrants further investigation. The failure of the
convalescent immune status to return to a pre-infection level may
indicate that GBV-B is capable of establishing an occult infection.
Further work is necessary, however, to determine the temporal
association between clearance or persistence of virus in both the
blood and the liver, and the liver pathology. Resolution of these
questions will be an important issue for hepacivirus research with
implications for HCV treatment and therapy.
5. Conclusion
Here we describe the dynamics of major lymphocyte popu-
lations at two  time points in GBV-B infection of tamarins;
high primary viremic phase and post-clearance of detectable
viraemia. We  observed a shift in the balance of CD3+ and
CD20+ cells and tissue-speciﬁc alterations in expression of the
activation/exhaustion marker PD-1. Critically, in the absence of
peripheral viraemia, we have observed ongoing viral replication in
the liver, which will impact on immunotherapy targeting for this
and related viruses. A limited cellular immune response against
GBV-B identiﬁed in the liver of tamarins supports the evidence of
ongoing virus replication but further studies will be required to
fully dissect the nature of this response. Future studies focusing
on CD8+ cytotoxic responses and CD4+ proliferative responses will
deﬁne the tamarin cell-mediated immune response against GBV-B.
Our results provide a foundation for more detailed investigations
of the acquired immune responses associated with elimination of
ﬂavivirus infection and add value to this surrogate model of HCV
infection.
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